Bg Klinik
- Address
- lock Available on a paid plan
BG Klinik - Burn Injury and Critical Care Research
BG Klinik is a specialized medical research center with expertise in the treatment and clinical investigation of severe burn injuries. The center focuses on advancing therapeutic interventions for critically ill patients suffering from life-threatening thermal trauma, with particular emphasis on improving outcomes in severely burned patients.
- High-dose intravenous vitamin C therapy for severe burn injuries
- Multi-organ dysfunction prevention in critical burn care
- Mortality reduction strategies in thermal injury patients
The center's research portfolio includes phase III multi-center randomized controlled trials examining innovative approaches to persistent organ dysfunction and survival outcomes in burn victims. Through rigorous investigation of adjunctive therapies combined with standard of care protocols, BG Klinik contributes to the evidence base for managing critically ill patients with severe thermal injuries requiring intensive care support.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
- 1Cutiss AG1active
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Bg Klinik
lock Showing 1 of 3 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of High-Dose Intravenous Ascorbic Acid on Persistent Organ Dysfunction and Mortality in Patients with Severe Burn Injury: A Phase III Randomized Trial | Queen's University | Phase II | Not Recruiting | Nov 2022 | Mar 2026 |
IMP list
lock Showing 1 of 3 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Ascorbic Acid | 1 | Unknown | 2022-11-22 | 2022-11-22 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.